4.4 Review

Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects

期刊

CLINICAL & TRANSLATIONAL ONCOLOGY
卷 24, 期 2, 页码 203-214

出版社

SPRINGER INT PUBL AG
DOI: 10.1007/s12094-021-02702-w

关键词

HAP1; Huntingtin; Huntington disease; Cancers; Tumor suppressor

类别

向作者/读者索取更多资源

Huntington disease is a genetic neurodegenerative disease caused by polyglutamine expansion, with HAP1 being a protein directly associated with the disease. HAP1 is expressed in the nervous system, endocrine system, and digestive system, and understanding its function can provide new insights into disease mechanisms.
Huntington disease (HD) is a single-gene autosomal dominant inherited neurodegenerative disease caused by a polyglutamine expansion of the protein huntingtin (HTT). Huntingtin-associated protein 1 (HAP1) is the first protein identified as an interacting partner of huntingtin, which is directly associated with HD. HAP1 is mainly expressed in the nervous system and is also found in the endocrine system and digestive system, and then involves in the occurrence of the related endocrine diseases, digestive system diseases, and cancer. Understanding the function of HAP1 could help elucidate the pathogenesis that HTT plays in the disease process. Therefore, this article attempts to summarize the latest research progress of the role of HAP1 and its application for diseases in recent years, aiming to clarify the functions of HAP1 and its interacting proteins, and provide new research ideas and new therapeutic targets for the treatment of cancer and related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据